Uzzo Robert G, Haas Naomi B, Crispen Paul L, Kolenko Vladimir M
Division of Urology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Cancer. 2008 Apr 15;112(8):1660-71. doi: 10.1002/cncr.23318.
New therapeutic strategies are needed to improve treatment outcomes in men with hormone-refractory prostate cancer. A better understanding of the molecular mechanisms of cell death in response to therapeutic strategies will help avoid ineffective treatment regimens and provide a molecular basis for new therapeutic modalities targeting apoptosis-resistant forms of prostate cancer. In this review, the authors focused on the established aberrations of apoptosis in hormone-refractory prostate cancer, and they have described novel treatment strategies to overcome apoptosis resistance.
需要新的治疗策略来改善激素难治性前列腺癌男性患者的治疗效果。更好地理解细胞对治疗策略反应的死亡分子机制,将有助于避免无效的治疗方案,并为针对抗凋亡形式前列腺癌的新治疗方式提供分子基础。在这篇综述中,作者聚焦于激素难治性前列腺癌中已确定的凋亡异常,并描述了克服凋亡抵抗的新治疗策略。